TY - JOUR
T1 - The use of surgery and radiotherapy as treatment of regional nodes in breast cancer patients
AU - Mitchell, Melissa P.
AU - Sharma, Priyanka
N1 - Publisher Copyright:
© 2019, UBM Medica Healthcare Publications. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Ipsilateral regional nodal status is an important independent prognostic factor for patients with breast cancer. Several decisions regarding local therapy are necessary for patients found to have pathologically involved lymph node(s). This article reviews the role of completion dissection and/or radiation therapy in patients found to have positive sentinel lymph node(s), taking into consideration use of mastectomy vs lumpectomy, tumor characteristics, tumor biology, plans for systemic therapy, and patient preferences. Published literature and current guidelines are reviewed, with emphasis on controversial topics such as regional nodal and postmastectomy radiation therapy for patients with one to three positive nodes. Choice of field design in patients undergoing radiation therapy will also be highlighted. Unique clinical situations such as locoregional treatment in patients receiving neoadjuvant chemotherapy and the emerging role of tumor biology and molecular assays in local therapy decision making will also be discussed.
AB - Ipsilateral regional nodal status is an important independent prognostic factor for patients with breast cancer. Several decisions regarding local therapy are necessary for patients found to have pathologically involved lymph node(s). This article reviews the role of completion dissection and/or radiation therapy in patients found to have positive sentinel lymph node(s), taking into consideration use of mastectomy vs lumpectomy, tumor characteristics, tumor biology, plans for systemic therapy, and patient preferences. Published literature and current guidelines are reviewed, with emphasis on controversial topics such as regional nodal and postmastectomy radiation therapy for patients with one to three positive nodes. Choice of field design in patients undergoing radiation therapy will also be highlighted. Unique clinical situations such as locoregional treatment in patients receiving neoadjuvant chemotherapy and the emerging role of tumor biology and molecular assays in local therapy decision making will also be discussed.
UR - http://www.scopus.com/inward/record.url?scp=85059641249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059641249&partnerID=8YFLogxK
M3 - Article
C2 - 29940065
AN - SCOPUS:85059641249
SN - 0890-9091
VL - 32
SP - e52-e64
JO - ONCOLOGY (United States)
JF - ONCOLOGY (United States)
IS - 6
ER -